U.S. patent number 3,870,042 [Application Number 05/295,687] was granted by the patent office on 1975-03-11 for apparatus for separating and injecting blood component.
This patent grant is currently assigned to Laboratories Medicoplast. Invention is credited to Leon Fernand Viguier.
United States Patent |
3,870,042 |
Viguier |
March 11, 1975 |
APPARATUS FOR SEPARATING AND INJECTING BLOOD COMPONENT
Abstract
The device comprises a system of blood-taking and decanting
pockets interconnected by tubes, a storage pocket, the dimensions
of which correspond to the amount of component to be injected, a
filter and injection means in this storage pocket. The device is
particularly useful for separating by cryo-precipitation and for
injecting into a patient the factor VIII used against
haemophilia.
Inventors: |
Viguier; Leon Fernand
(Saint-Pierre de Mesage, FR) |
Assignee: |
Laboratories Medicoplast (Paris
(Seine), FR)
|
Family
ID: |
9084287 |
Appl.
No.: |
05/295,687 |
Filed: |
October 6, 1972 |
Foreign Application Priority Data
|
|
|
|
|
Oct 13, 1971 [FR] |
|
|
71.36734 |
|
Current U.S.
Class: |
604/406;
604/410 |
Current CPC
Class: |
A61M
39/221 (20130101); A61M 1/0218 (20140204); A61M
1/02 (20130101); A61M 2205/7545 (20130101); A61M
2202/0454 (20130101); A61M 2202/0454 (20130101); A61M
2202/0014 (20130101) |
Current International
Class: |
A61M
1/02 (20060101); A61M 39/22 (20060101); A61M
39/00 (20060101); A61m 005/00 () |
Field of
Search: |
;128/214R,214D,214E,272,214.2 |
References Cited
[Referenced By]
U.S. Patent Documents
Primary Examiner: Medbery; Aldrich F.
Claims
I claim:
1. In an apparatus for sampling and fractionating blood components
including a plurality of sampling and fractionating pockets
interconnected by tubing, a means for sequentially isolating,
storing and intravenously injecting into a patient a blood
component present in small amounts in the blood and liable to
contain agglomerated elements,
said means comprising:
a distinct storage pocket for said component,
the inlet of said storage pocket being connected by sectionable
tubing to said plurality of sampling and fractionating pockets,
the outlet of said storage pocket being sealed and having means for
being equipped with injection means;
a filter means for preventing the injection of the agglomerated
elements incorporated inside said storage pocket between said inlet
and said outlet; said storage pocket being of dimensions
substantially corresponding to the quantity of the component
separated.
2. An apparatus according to claim 1, wherin said filter means
consists of a tubular length of a filter fabric in the form of a
sleeve running longitudinally inside said storage pocket,
one end of said sleeve being held closed at the bottom of said
storage pocket,
the other end surrounding an outlet ferrule, said other end and
said ferrule being held at the top of said storage pocket.
3. An apparatus according to claim 1, wherein said storage pocket
is composed of two sheets having sides welded together; said filter
means consisting of a tubular length of a filter fabric in the form
of a sleeve running longitudinally inside said storage pocket,
one end of said sleeve being held closed between said sheets by the
weld at the bottom of said storage pocket,
the other end surrounding an outlet ferrule, said other end and
said ferrule being held between said sheets by the weld at the top
of said storage pocket.
4. An apparatus according to claim 2, wherein said injection means
is integral with said outlet ferrule.
5. An apparatus according to claim 2, wherein said outlet ferrule
is further surrounded by a sterile access port, said injection
means being adaptable to said access port.
Description
The present invention relates to a method and apparatus for
separating, isolating and injecting certain blood components. More
particularly, the invention relates to a device comprising a system
of flexible pockets interconnected by means of tubes and intended
to take up blood components and to separate them, especially by
decanting.
In one known device, blood is taken from the donor's vein and is
stored in a first blood-taking pocket, where it undergoes a first
treatment for initial separation. One of the components is then
transferred to a second pocket in the system for a second
separation treatment. One of the elements separated after this
second treatment is passed to a final pocket where it is
stored.
The element thus separated and intended to be injected into a
patient is taken from this storage pocket by means of a hollow
needle which is used to pierce the pocket. In the case of a blood
component containing agglomerated elements, however, the device
just described has disadvantages, since the agglomerated particles
may obstruct the passage in the hollow needle or may enter the
patient's vein and create circulation problems. Incidents of this
kind generally occur where the blood component has been separated
by cryo-precipitation, since agglomerated elements still remain
after thawing. In order to avoid such incidents, it is usual to
dilute the component in a solution, especially an isotonic
solution, before injecting it into the patient. This operation is
usually carried out in an adjacent pocket into which the
constituent taken is introduced by means of the hollow needle.
For the purpose of overcoming these disadvantages, it is also known
to filter the blood before injecting it into the patient. A
transfusion device of this kind is described in U.S. Pat. No.
2,702,034 filed on July 20, 1950. The filter chamber, usually of
large capacity, is integrated into the means of transfusion and the
dead volume of the latter therefore makes it impossible to use it
for injecting small quantities.
Finally it is very difficult to remove the liquid from the storage
pocket in a perfectly sterile manner in order to dilute it in the
isotonic solution and inject it, while eliminating any risk of
contamination of the element to be injected.
It is an object of this invention to provide a method and an
apparatus to overcome these disadvantages and difficulties. The
method in accordance with the present invention consists in the
following steps:
THE COMPONENT IS TRANSFERRED IN A STERILE MANNER TO A STORAGE
POCKET CONNECTED TO THE SYSTEM OF BLOOD-TAKING AND DECANTING
POCKETS, THE POCKET COMPRISING AN INTERNAL FILTER AND HAVING
DIMENSIONS CORRESPONDING TO THE AMOUNT OF COMPONENT ISOLATED;
THE STORAGE POCKET IS SEPARATED FROM THE SYSTEM OF BLOOD-TAKING AND
DECANTING POCKETS, AND
THE COMPONENT IS KEPT IN THE STORAGE POCKET UNTIL IT IS INJECTED
INTO THE PATIENT'S VEIN.
According to one embodiment of the invention, before the component
just isolated is transferred to the storage pocket, it is mixed
with a rinsing solution, especially an isotonic solution, which
dilutes, in part, the agglomerated elements; this rinsing solution
is contained in a pocket connected in a sealed and sterile manner
to the system of blood-taking and decanting pockets.
The apparatus made in accordance with the present invention
consists of a storage pocket containing a filter and having
dimensions corresponding to the quantity of component isolated. The
arrangement of the filter within the storage pocket is essential,
since it produces a device which is particularly compact and easy
to use, in which dead volumes are greatly limited. This is
essential if the quantities of component extracted from the blood
are very small.
According to another embodiment of the invention, the storage
pocket also comprises injection means adapted to the end of the
filter. The purpose of this arrangement is to avoid contamination
of the components in the storage pocket at the time of their
injection, but this highly compact arrangement of the injection
means also helps to greatly limit dead volumes.
According to another embodiment of the apparatus of the invention,
the isotonic solution is kept, prior to use, in the storage pocket.
Thus the storage pocket, which comprises a filter and injection
means, contains a solution of the blood component already diluted
and ready to be injected.
The invention will now be described in greater detail in
conjunction with two forms of embodiment given by way of examples
only, and illustrated in the attached drawings, wherein:
FIG. 1 shows a side elevational view of the device according to the
invention;
FIG. 2 shows a side elevational view of the storage pocket, partly
broken away and to an enlarged scale; and
FIG. 3 shows a side elevational view of another embodiment of the
device according to the invention.
Illustrated in FIG. 1 is a device which comprises a first flexible
pocket 1 made of transparent synthetic material. Opening into this
pocket is the end of a flexible tube 3 made of weldable synthetic
material, the other end thereof being integral with a hollow needle
4 protected by a sleeve 5.
Opening into pocket 1 is one end of a tube 8 made of weldable
synthetic material, the other end of which is integral with one arm
of a three-way union 9, the other two arms of which are connected
respectively, through tubes 11 and 12, to flexible pockets 6 and
10. Pocket 10 is connected through a tube 13 to a storage pocket 14
made of two sheets of synthetic material welded together by their
edges. Pocket 14 contains a filter 17 and injection means
consisting, more particularly, of a tube 23 comprising an injection
needle 15 protected by a cap 16.
Filter 17, seen in FIG. 2, consists of a piece of fabric in the
form of a sleeve, one end thereof being held by the weld at the
bottom of the pocket, while the other end accommodates a ferrule 18
to which it is attached by the weld joining together the two sheets
of which the pocket is made.
In one particular configuration of the invention, ferrule 18 has an
internal wall 19 intended to be pierced by a hollow needle 20
integral with a sleeve 21 connected to the injection needle by
means of a tube 23.
A description will now be given of the method of using the device
illustrated in FIGS. 1 and 2. Hollow needle 4 is inserted into the
patient's vein. After the blood has been collected in pocket 1,
tube 3 is flattened in the vicinity of the pocket and its walls are
welded together in order to close it off. The remainder of the
tube, which is no longer in use, is then cut off.
The plasma is separated from the blood in some way, for example by
centrifuging, after which the plasma is passed through tubes 8 and
11 into pocket 6, tube 12 being closed off by means of a clamp.
The plasma in pocket 6 is subjected to a treatment, such as
cryo-precipitation, in order to separate an element (such as factor
VIII) used against haemophilia. After tube 8 has been closed off,
the element of the blood to be separated is decanted, through tubes
11 and 12, into pocket 10 which contains an isotonic solution to be
mixed with the element. This mixture is then transferred to pocket
14 through tube 13.
Another way of using the present device consists in passing the
plasma contained in pocket 1 through tubes 8 and 12 into pocket 10,
tube 11 being closed off, for example by means of a clamp. The
component contained in the plasma (more particularly factor VIII
which is used against haemophilia) is separated by
cryo-precipitation in pocket 10. The unprecipitated fraction of the
plasma is transferred to pocket 6 through tubes 11 and 12, after
tube 8 has been closed off, for example with a clamp. The isotonic
solution, which in this configuration of the invention, is
contained in storage pocket 14, is transferred to pocket 10 where
it is used to dilute the component separated by cryo-precipitation.
Pocket 10 is carefully rinsed with this solution, and the mixture
of isotonic solution and component is transferred to pocket 14
through tube 13.
Tube 13 is then flattened and welded and pocket 14 is then
separated from pocket 10 by cutting the tube. The blood elements in
pockets 1 and 6 are then retained for specific purposes, while the
component in pocket 14 may be kept therein until it is required for
use.
At the time of use, sleeve 21 is pushed into ferrule 18 in a manner
such that needle 20 pierces wall 19, after which needle 15 is
inserted into the patient's vein and the component in its isotonic
solution is injected directly by rolling up pocket 14 in order to
force the liquid through tube 23. The agglomerated elements cannot
pass through filter 17 and they therefore remain in pocket 14. Dead
volumes are limited to a minimum since pocket 14 is small in size
and the useful volume thereof corresponds substantially to the
volume of component placed in solution for injection into the
patient; moreover, the filter means is integrated into the storage
pocket. A device of this kind also prevents contamination and
ensures storage and injection under completely sterile
conditions.
FIG. 3 shows blood-taking pocket 1 with its means for taking blood,
namely hollow needle 4 protected by cap 5. This pocket is
connected, through tube 32, to a second pocket 30 which is
connected in turn, through a tube 33, to a third pocket 31 and,
through a tube 34, to a storage pocket 14. This latter pocket
comprises a filter 17 integral with a ferrule 18 as described in
connection with FIG. 2, the ferrule being integral with a sterile
access port 35, and the end of the ferrule being adaptable to the
injection means.
The method of using this device to isolate and inject a component
containing agglomerated elements will now be described.
The blood taken from the subject's vein is subjected to initial
fractionation in pocket 1, more particularly by centrifuging. The
plasma is transferred, through tube 32, to pocket 30, after which
the tube is heat sealed or welded and cut off. The plasma in pocket
30 is again fractionated, more particularly by cryo-precipitation,
in order to isolate those components which are present in very
small quantities in human blood and which possess therapeutical
properties. After being thawed out, the liquid fraction of the
plasma is transferred, through tube 33, to pocket 31, during which
transfer tube 34 is closed off, for example with a clamp. After
tube 32 has been closed off, the rinsing solution in storage pocket
14 is passed, through tube 34, into pocket 30 which contains the
component separated by cryo-precipitation. The mixture thus
obtained is again transferred to pocket 14, where it is retained
after tube 34 has been welded and cut off. During this latter
operation, sterile air trapped in pocket 14 is evacuated through
tube 34, so that pocket 14 is completely filled. In order to inject
the solution containing the component into the patient's vein, a
catheter containing a tube of very small cross section is connected
to pocket 14. This catheter is fitted to ferrule 18 in access port
35 after the port has been opened under sterile conditions. The
liquid is then injected by compressing pocket 14. The agglomerated
elements are retained in pocket 14 by filter 17. Moreover, there is
no risk of introducing air into the patient's vein, since care is
taken to remove the air from pocket 14 before it is sealed.
Moreover, the dead volume of the injection tube is as small as
possible, and almost the entire amount of the solution contained in
the storage pocket is injected. Finally, the injection means may be
disconnected from access port 35 in pocket 14 and connected to a
new pocket. It is thus possible to inject into the patient's vein
as many doses as may be required, with no fear of the fine
injection tube becoming blocked.
It is to be understood that the invention is not restricted in
interpretation except by the scope of the following claims.
* * * * *